MedTrace Logo

An Intervention Study on Transcranial Photobiomodulation in Children With Attention Deficit Hyperactivity Disorder

NCT06685601 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-07-22

No results posted yet for this study

Summary

This study aims to intervene in children and adolescents with ADHD using transcranial photobiomodulation, comparing its effects on executive function at the levels of electroencephalography (EEG), eye tracking, and cognitive behavior. The goal is to identify the most effective clinical treatment strategy for ADHD patients.

Conditions

  • ADHD - Attention Deficit Disorder With Hyperactivity

Interventions

DEVICE

tPBM（active）

During the active stimulation condition, participants will receive a single session of tPBM intervention, lasting 12 minutes.

DEVICE

tPBM（sham）

During the sham stimulation condition, participants will receive the same intervention with identical target areas and wavelength, but only for the first and last 30 seconds of the session.

Sponsors & Collaborators

  • Capital Medical University

    collaborator OTHER

  • Peking Union Medical College

    collaborator OTHER

  • Chinese Academy of Medical Sciences

    collaborator OTHER

  • Qilu Hospital of Shandong University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-16
Primary Completion
2026-11-30
Completion
2027-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06685601 on ClinicalTrials.gov